Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Published 13 February 2009, doi:10.1136/bmj.b140
Cite this as: BMJ 2009;338:b140
A range of options that provide reliable and reproducible results is essential
| The first 150 words of the full text of this article appear below. |
Screening for Downs syndrome is the most controversial aspect of antenatal care offered to pregnant women, and it is a highly emotionally charged subject. In a recent editorial, two senior executives of Down Syndrome Education International claimed that current public health policies leading to an estimated annual loss of 400 normal fetuses to prevent the birth of 600 babies with Downs syndrome were "shocking."1 Both the estimated numbers and the tone of the statement were disputed by—among others—members of the editorial board of the journal published by Down Syndrome Education International.2
Two BMJ papers provide additional information for the debate. In the first, Ekelund and colleagues (doi:10.1136/bmj.a2547) described real life data from Denmark after the introduction of the first trimester combined screening programme in 2005.3 In the second (doi:10.1136/bmj.b138), Gekas and colleagues calculated the cost effectiveness of 19 different screening algorithms using data generated by computer
Zarko Alfirevic, professor of fetal and maternal medicine
1 University of Liverpool, Liverpool Womens Hospital, Liverpool L8 7SS
zarko@liv.ac.uk
Read all Rapid Responses